7PL Stock Overview
A medical technology company, develops, manufactures, and sells urological devices and treatments in Sweden and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
ProstaLund AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.74 |
| 52 Week High | SEK 5.24 |
| 52 Week Low | SEK 0.008 |
| Beta | 0.56 |
| 1 Month Change | 9,101.25% |
| 3 Month Change | 253.89% |
| 1 Year Change | -81.87% |
| 3 Year Change | -95.49% |
| 5 Year Change | n/a |
| Change since IPO | -90.46% |
Recent News & Updates
Recent updates
Shareholder Returns
| 7PL | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 9,101.3% | -3.2% | -2.0% |
| 1Y | -81.9% | -8.4% | 6.8% |
Return vs Industry: 7PL underperformed the German Medical Equipment industry which returned -8.4% over the past year.
Return vs Market: 7PL underperformed the German Market which returned 6.8% over the past year.
Price Volatility
| 7PL volatility | |
|---|---|
| 7PL Average Weekly Movement | 5,431.6% |
| Medical Equipment Industry Average Movement | 6.6% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.4% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 7PL's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 7PL's weekly volatility has increased from 2888% to 5432% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | 9 | Anders Kristensson | prostalund.se |
ProstaLund AB (publ), a medical technology company, develops, manufactures, and sells urological devices and treatments in Sweden and internationally. It offers CoreTherm, a heat treatment for benign prostate enlargement; CoreFlow soft stent; Oruflow, a urine flow meter; Dosi-Fuser, a disposable continuous infusion system; and Dosi-Flow, a gravitation unit with a flow regulator for dosing of medicines. The company also provides Schelin Catheter, an injection tool that allows the urologists to administer drugs into the prostate in a sterile way through the urethra.
ProstaLund AB (publ) Fundamentals Summary
| 7PL fundamental statistics | |
|---|---|
| Market cap | €2.41m |
| Earnings (TTM) | -€1.74m |
| Revenue (TTM) | €1.42m |
1.7x
P/S Ratio-1.4x
P/E RatioIs 7PL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7PL income statement (TTM) | |
|---|---|
| Revenue | SEK 16.34m |
| Cost of Revenue | SEK 4.86m |
| Gross Profit | SEK 11.48m |
| Other Expenses | SEK 31.42m |
| Earnings | -SEK 19.94m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 20, 2025
| Earnings per share (EPS) | -6.48 |
| Gross Margin | 70.29% |
| Net Profit Margin | -122.04% |
| Debt/Equity Ratio | 1.8% |
How did 7PL perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 13:24 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
ProstaLund AB (publ) is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Markus Augustsson | Carlsquare AB |